| Aug 15, 2014
| 8:21 AM
(Reuters) - Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent.
The mid-stage trial tested Achillion's...
| Aug 13, 2014
| 5:00 PM
The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...
| Aug 4, 2014
| 12:17 PM
CHICAGO (Reuters) - (The opinions expressed here are those of the author, a columnist for Reuters.)
For healthcare, gray is the new black.
The fastest-growing segment of the global population is aged 60 and over, according to the United Nations...
| Sep 25, 2011
| 3:31 AM
STOCKHOLM (Reuters) - Roche's bone strengthening drug Boniva is as good for pain relief as single dose radiotherapy in patients whose prostate cancer has spread to their bones, according to data from a late-stage trial released on Sunday.
| Jul 18, 2012
| 11:43 AM
LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.
The United Nations...
| Aug 25, 2010
Q: I'm 79 and had chickenpox as a child. Should I get the shingles vaccine? What are the risks?
A: The U.S. Advisory Committee on Immunization Practices (ACIP) recommends the shingles vaccine for most people ages 60 and over, regardless of whether they...
| May 24, 2010
Crystal Lake's Peggy Lim has a healthy respect for the sun's powerful ultraviolet rays, and on a recent shopping trip she agonized over choosing a sunscreen for her three children.
"I've always heard the higher the SPF (sun protection factor) the better,...
| Nov 14, 2013
| 4:38 PM
Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
| May 10, 2011
| 2:49 PM
Heart patients who used common pain relievers called NSAIDs even briefly are at much higher risk of having a repeat heart attack or of dying than those who stay away from the drugs, which include such widely used over-the-counter medications as...
| Jun 14, 2010
| 4:06 PM
In a rare move, federal regulators are seeking to disqualify a prominent Chicago HIV doctor from future drug studies after they discovered his clinic committed one of the most grievous sins of medical research: submitting fictitious data in a drug trial....
| Aug 14, 2011
Among the hundreds of drastic and unproven weight loss plans, the controversial hCG diet may take the cake.
Discredited by researchers in the 1970s, the near-starvation diet restricts followers to 500 calories a day for six weeks. At the same time,...